These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1096811)

  • 21. [Antibacterial in-vitro activity of pipemidic acid and nalidixic acid (author's transl)].
    Peters G; Freiesleben H; Marre R; Metz H; Tannenberg H; Pulverer G
    Dtsch Med Wochenschr; 1979 Jun; 104(26):946-8. PubMed ID: 110574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro sensitivity pattern of gram negative pathogens to nalidixic acid.
    Chitkara YK
    Indian J Pathol Bacteriol; 1969 Oct; 12(4):162-8. PubMed ID: 4990210
    [No Abstract]   [Full Text] [Related]  

  • 23. Antibacterial activity of miloxacin.
    Izawa A; Kisaki Y; Irie K; Eda Y; Nakagome T; Komatsu T
    Antimicrob Agents Chemother; 1980 Jul; 18(1):37-40. PubMed ID: 7416749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mode of action of a new nalidixic acid derivative, AB206.
    Nagate T; Komatsu T; Izawa A; Ohmura S; Namiki S; Mitsuhashi S
    Antimicrob Agents Chemother; 1980 May; 17(5):763-9. PubMed ID: 6156644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activity of norfloxacin in urine compared to that of cinnoxacin, nalidixic acid and pipemidic acid.
    Shah PM; Ottrad M; Stille W
    Eur J Clin Microbiol; 1983 Jun; 2(3):272-4. PubMed ID: 6224688
    [No Abstract]   [Full Text] [Related]  

  • 26. Compound 64716, a new synthetic antibacterial agent.
    Wick WE; Preston DA; White WA; Gordee RS
    Antimicrob Agents Chemother; 1973 Oct; 4(4):415-20. PubMed ID: 4791302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibacterial activity after a single-dose of norfloxacin, ofloxacin and pipemidic acid detected in urine of volunteers.
    Cruciani M; Monzillo V; Navarra A; Tinelli C; Concia E
    Drugs Exp Clin Res; 1988; 14(8):533-7. PubMed ID: 3150350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of nalidixic acid, pipemidic acid and cinoxacin on chondrocyte metabolism in explants of articular cartilage.
    Brand HS; van Kampen GP; van der Korst JK
    Clin Exp Rheumatol; 1990; 8(4):393-5. PubMed ID: 2397627
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nalidixic acid: an antibacterial paradox.
    Crumplin GC; Smith JT
    Antimicrob Agents Chemother; 1975 Sep; 8(3):251-61. PubMed ID: 1101818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro activities of ciprofloxacin, norfloxacin, pipemidic acid, cinoxacin, and nalidixic acid against Chlamydia trachomatis.
    Heessen FW; Muytjens HL
    Antimicrob Agents Chemother; 1984 Jan; 25(1):123-4. PubMed ID: 6230988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activity of flomoxef and comparators against Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis producing extended-spectrum β-lactamases in China.
    Yang Q; Zhang H; Cheng J; Xu Z; Xu Y; Cao B; Kong H; Ni Y; Yu Y; Sun Z; Hu B; Huang W; Wang Y; Wu A; Feng X; Liao K; Shen D; Hu Z; Chu Y; Lu J; Su J; Gui B; Duan Q; Zhang S; Shao H
    Int J Antimicrob Agents; 2015 May; 45(5):485-90. PubMed ID: 25600890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigation into the antibacterial activity in vitro of cement-antibiotic mixtures.
    Greco F; Rossi A; De Palma L; Spagnolo N
    Ital J Orthop Traumatol; 1981 Apr; 7(1):103-13. PubMed ID: 6799427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro studies with sisomicin and gentamicin.
    Shadomy S; Utz CJ; Shadomy HJ
    Chemotherapy; 1976; 22(6):346-52. PubMed ID: 821725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacology of cinoxacin in humans.
    Black HR; Israel KS; Wolen RL; Brier GL; Obermeyer BD; Ziege EA; Wolny JD
    Antimicrob Agents Chemother; 1979 Feb; 15(2):165-70. PubMed ID: 426511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of inoculum size on ampicillin and amoxycillin susceptibility determined by gas-liquid chromatography for members of the family Enterobacteriaceae.
    Hayward NJ
    J Clin Microbiol; 1986 Apr; 23(4):755-9. PubMed ID: 3517063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bactericidal effect of combinations of nalidixic acid and various antibiotics on Enterobacteriaceae.
    Michel J; Luboshitzky R; Sacks T
    Antimicrob Agents Chemother; 1973 Sep; 4(3):201-4. PubMed ID: 4758830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of pH on the in vitro susceptibility of planktonic and biofilm-grown Proteus mirabilis to the quinolone antimicrobials.
    Irwin NJ; McCoy CP; Carson L
    J Appl Microbiol; 2013 Aug; 115(2):382-9. PubMed ID: 23647563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Technique for determining the bactericidal effect of drug combinations.
    Lorian V; Fodor G
    Antimicrob Agents Chemother; 1974 Jun; 5(6):630-3. PubMed ID: 15825416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibacterial activities of ciprofloxacin, norfloxacin, oxolinic acid, cinoxacin, and nalidixic acid.
    Barry AL; Jones RN; Thornsberry C; Ayers LW; Gerlach EH; Sommers HM
    Antimicrob Agents Chemother; 1984 May; 25(5):633-7. PubMed ID: 6233935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobial resistance trends in Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis urinary isolates from Switzerland: retrospective analysis of data from a national surveillance network over an 8-year period (2009-2016).
    Zanichelli V; Huttner A; Harbarth S; Kronenberg A; Huttner B; Swiss Centre For Antibiotic Resistance Anresis
    Swiss Med Wkly; 2019 Jul; 149():w20110. PubMed ID: 31340052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.